| Is Your Portfolio Ready for KamalaEconomics? (ad)Kamala Harris is the official Democratic nominee, and with her comes a new era of economic policy. Is your portfolio prepared for the potential market shakeup? Discover the assets you need to protect your investments in uncertain times.
By following the link above or using any of the links provided below, you're choosing to opt in to receive insightful updates from Wealth Creation Investing + 2 free bonus subscriptions! Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details. Download the Free Guide Now |
|
Today's Top Stories | | By Thomas Hughes | October 31, 2024 09:46 AM |
| | | By The Associated Press | October 30, 2024 10:36 PM |
| | By Gabriel Osorio-Mazilli | October 31, 2024 08:15 AM |
| | | By The Associated Press | October 30, 2024 10:08 PM |
| | By Ryan Hasson | October 31, 2024 08:00 AM |
|
|
Your Watchlist | | | - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
| - Meta Platforms (NASDAQ:META) announced its quarterly results on Wednesday, October 30th. The company reported $6.03 earnings per share (EPS) for the previous quarter, beating the consensus estimate of $5.19 EPS by $0.84. The company had revenue of $40.59 billion for the quarter, compared to the consensus estimate of $40.21 billion. Meta Platforms also updated its Q4 2024 guidance to EPS.
- Meta Platforms (NASDAQ:META) had its price target raised by Pivotal Research ( ) (analyst J. Wlodarczak) from $780.00 to $800.00. They now have a "buy" rating on the stock. This represents a 39.4% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities ( ). They now have a $811.00 price target on the stock. This represents a 41.3% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by Monness Crespi & Hardt ( ) (analyst B. White) from $620.00 to $660.00. They now have a "buy" rating on the stock. This represents a 15.0% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by analysts at Bank of America Co. ( ) from $630.00 to $660.00. They now have a "buy" rating on the stock. This represents a 15.0% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by analysts at BMO Capital Markets ( ) from $525.00 to $530.00. They now have a "market perform" rating on the stock. This represents a 7.7% downside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by analysts at Robert W. Baird ( ) from $605.00 to $630.00. They now have an "outperform" rating on the stock. This represents a 9.8% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by analysts at Mizuho ( ) from $650.00 to $675.00. They now have an "outperform" rating on the stock. This represents a 17.6% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by analysts at Piper Sandler ( ) from $575.00 to $650.00. They now have an "overweight" rating on the stock. This represents a 13.2% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by analysts at Barclays PLC ( ) from $550.00 to $630.00. They now have an "overweight" rating on the stock. This represents a 9.8% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target raised by analysts at JPMorgan Chase & Co. ( ) from $640.00 to $660.00. They now have an "overweight" rating on the stock. This represents a 15.0% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its price target lowered by Scotiabank ( ) (analyst N. Schindler) from $585.00 to $583.00. They now have a "sector perform" rating on the stock. This represents a 1.6% upside from the current price of $573.96.
- Meta Platforms (NASDAQ:META) had its "underperform" rating reaffirmed by analysts at Needham & Company LLC ( ).The current price is $573.96.
- (10/31) Mizuho Issues Positive Forecast for Meta Platforms (NASDAQ:META) Stock Price (marketbeat.com)
- (10/31) Meta targets raised as analysts hail ad growth, bat off light forecast (proactiveinvestors.com)
- (10/31) How 2 Big Tech Titans Are Faring After Earnings (schaeffersresearch.com)
- (10/31) Meta Platforms (NASDAQ:META) Receives "Underperform" Rating from Needham & Company LLC (marketbeat.com)
- (10/31) Microsoft, Meta Platforms Drag Down Nasdaq Futures: Markets Wrap (yahoo.com)
| - Microsoft (NASDAQ:MSFT) announced its quarterly results after the market closed on Wednesday, October 30th. The company reported $3.30 earnings per share (EPS) for the previous quarter, beating the consensus estimate of $3.08 EPS by $0.22. The company had revenue of $65.59 billion for the quarter, compared to the consensus estimate of $64.57 billion. During the same quarter in the prior year, the company posted $2.99 earnings per share. The company's quarterly revenue was up 16.0% on a year-over-year basis. Microsoft also updated its Q2 2025 guidance to EPS. View earnings release. View earnings call transcript.
- Microsoft's (NASDAQ:MSFT) earnings call transcript is now available on MarketBeat. Read the transcript here.
- Microsoft (NASDAQ:MSFT) had its price target lowered by analysts at TD Cowen ( ) from $495.00 to $475.00. They now have a "buy" rating on the stock. This represents a 15.9% upside from the current price of $410.00.
- Microsoft (NASDAQ:MSFT) had its price target lowered by analysts at BMO Capital Markets ( ) from $500.00 to $495.00. They now have an "outperform" rating on the stock. This represents a 20.7% upside from the current price of $410.00.
- Microsoft (NASDAQ:MSFT) had its "overweight" rating reaffirmed by analysts at Piper Sandler ( ). They now have a $470.00 price target on the stock. This represents a 14.6% upside from the current price of $410.00.
- Microsoft (NASDAQ:MSFT) had its price target raised by analysts at Morgan Stanley ( ) from $506.00 to $548.00. They now have an "overweight" rating on the stock. This represents a 33.7% upside from the current price of $410.00.
- (10/31) Microsoft (NASDAQ:MSFT) Given New $475.00 Price Target at TD Cowen (marketbeat.com)
- (10/31) Microsoft Can Hit New All-Time Highs This Year - Here's Why (marketbeat.com)
- (10/31) How 2 Big Tech Titans Are Faring After Earnings (schaeffersresearch.com)
- (10/31) Microsoft (MSFT) Faces $1.5 Billion Loss From OpenAI Investment (gurufocus.com)
- (10/31) Microsoft and Meta's Earnings Underscore AI Investment Concerns (gurufocus.com)
|
| Manage Your Watchlist
|
Analysts' Upgrades | Banc of California (NYSE:BANC) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $18.00 price target on the stock, up previously from $17.00. This represents a 15.6% upside from the current price of $15.57. | Danaher (NYSE:DHR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $285.00 price target on the stock. This represents a 15.6% upside from the current price of $246.57. | Electronic Arts (NASDAQ:EA) was upgraded by analysts at DZ Bank AG from a "hold" rating to a "buy" rating. They now have a $177.00 price target on the stock, up previously from $135.00. This represents a 18.3% upside from the current price of $149.57. | Alphabet (NASDAQ:GOOGL) was upgraded by analysts at China Renaissance from a "hold" rating to a "buy" rating.The current price is $173.88. | KLA (NASDAQ:KLAC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $850.00 price target on the stock, up previously from $750.00. This represents a 26.8% upside from the current price of $670.28. | L3Harris Technologies (NYSE:LHX) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $300.00 price target on the stock, up previously from $240.00. This represents a 21.8% upside from the current price of $246.36. | Meritage Homes (NYSE:MTH) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $235.00 price target on the stock, up previously from $205.00. This represents a 30.7% upside from the current price of $179.86. | Envista (NYSE:NVST) was upgraded by analysts at Leerink Partners from an "underperform" rating to a "market perform" rating. They now have a $23.00 price target on the stock, up previously from $16.00. This represents a 7.0% upside from the current price of $21.49. | Omega Healthcare Investors (NYSE:OHI) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating. They now have a $49.00 price target on the stock. This represents a 12.9% upside from the current price of $43.40. | OneSpan (NASDAQ:OSPN) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $19.00 price target on the stock, up previously from $14.00. This represents a 12.9% upside from the current price of $16.83. | Remitly Global (NASDAQ:RELY) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $18.00 price target on the stock, up previously from $13.00. This represents a 0.3% upside from the current price of $17.94. | Regions Financial (NYSE:RF) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $28.00 price target on the stock, up previously from $27.00. This represents a 16.3% upside from the current price of $24.07. | Smurfit Westrock (NYSE:SW) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $58.00 price target on the stock, up previously from $52.00. This represents a 11.9% upside from the current price of $51.82. | Valley National Bancorp (NASDAQ:VLY) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $10.00 price target on the stock, up previously from $9.00. This represents a 5.9% upside from the current price of $9.44. | Wingstop (NASDAQ:WING) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $370.00 price target on the stock. This represents a 24.9% upside from the current price of $296.31. | Wingstop (NASDAQ:WING) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $340.00 price target on the stock. This represents a 14.7% upside from the current price of $296.31. |
| View More Upgrades
|
Analysts' Downgrades | ARM (NASDAQ:ARM) was downgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "underperform" rating. They now have a $100.00 price target on the stock. This represents a 29.3% downside from the current price of $141.40. | Biogen (NASDAQ:BIIB) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $204.00 price target on the stock, down previously from $285.00. This represents a 16.4% upside from the current price of $175.23. | Blackbaud (NASDAQ:BLKB) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $80.00 price target on the stock, down previously from $92.00. This represents a 6.8% upside from the current price of $74.92. | Brinker International (NYSE:EAT) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $105.00 price target on the stock, up previously from $80.00. This represents a 0.5% upside from the current price of $104.45. | Brinker International (NYSE:EAT) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $100.00 price target on the stock, up previously from $67.00. This represents a 4.3% downside from the current price of $104.45. | Estée Lauder Companies (NYSE:EL) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $125.00 price target on the stock. This represents a 74.2% upside from the current price of $71.75. | Estée Lauder Companies (NYSE:EL) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $80.00 price target on the stock, down previously from $105.00. This represents a 11.5% upside from the current price of $71.75. | Enovix (NASDAQ:ENVX) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating. They now have a $10.00 price target on the stock. This represents a 10.5% upside from the current price of $9.05. | First Interstate BancSystem (NASDAQ:FIBK) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $30.00 price target on the stock, down previously from $32.00. This represents a 3.8% downside from the current price of $31.18. | GSK (NYSE:GSK) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $36.28. | Kraft Heinz (NASDAQ:KHC) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $35.00 price target on the stock, down previously from $39.00. This represents a 4.4% upside from the current price of $33.52. | Option Care Health (NASDAQ:OPCH) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $26.00 price target on the stock, down previously from $38.00. This represents a 11.9% upside from the current price of $23.23. | Super Micro Computer (NASDAQ:SMCI) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $27.56. | TE Connectivity (NYSE:TEL) was downgraded by analysts at HSBC Holdings plc from a "hold" rating to a "reduce" rating. They now have a $137.00 price target on the stock. This represents a 7.9% downside from the current price of $148.71. | Trane Technologies (NYSE:TT) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $405.00 price target on the stock. This represents a 10.3% upside from the current price of $367.07. | WillScot Mobile Mini (NASDAQ:WSC) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $35.00 price target on the stock, down previously from $46.00. This represents a 5.6% upside from the current price of $33.15. |
| View More Downgrades
|
Analysts' New Coverage | Alumis (NASDAQ:ALMS) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $25.00 price target on the stock. This represents a 118.3% upside from the current price of $11.45. | Braze (NASDAQ:BRZE) is now covered by analysts at Macquarie. They set a "neutral" rating and a $30.00 price target on the stock. This represents a 5.2% downside from the current price of $31.63. | CEMIG (NYSE:CIG) is now covered by analysts at Scotiabank. They set a "sector perform" rating on the stock.The current price is $1.94. | Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $5.00 price target on the stock. This represents a 63.9% upside from the current price of $3.05. | Klaviyo (NYSE:KVYO) is now covered by analysts at Macquarie. They set a "neutral" rating and a $36.00 price target on the stock. This represents a 5.2% downside from the current price of $37.97. | MDxHealth (NASDAQ:MDXH) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $7.00 price target on the stock. This represents a 236.5% upside from the current price of $2.08. | ORIC Pharmaceuticals (NASDAQ:ORIC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $20.00 price target on the stock. This represents a 109.0% upside from the current price of $9.57. | Terns Pharmaceuticals (NASDAQ:TERN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $82.00 price target on the stock. This represents a 1100.6% upside from the current price of $6.83. | Vanda Pharmaceuticals (NASDAQ:VNDA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock. This represents a 287.1% upside from the current price of $4.65. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | Join Now |
|
|
No comments:
Post a Comment